Latest Insider Transactions at Vyant Bio, Inc. (VYNT)
This section provides a real-time view of insider transactions for Vyant Bio, Inc. (VYNT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vyant Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vyant Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 11
2016
|
Raju S.K. Chaganti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.77%
|
-
|
|
Oct 11
2016
|
Edmund Cannon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+15.73%
|
-
|
|
Oct 11
2016
|
Franklyn G Prendergast Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+25.0%
|
-
|
|
Aug 16
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
45,000
+1.93%
|
$90,000
$2.29 P/Share
|
|
Aug 15
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
79,722
+3.43%
|
$159,444
$2.2 P/Share
|
|
Aug 12
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
67,778
+3.04%
|
$135,556
$2.1 P/Share
|
|
May 25
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
317,820
+13.15%
|
-
|
|
Mar 17
2016
|
Howard Mc Leod Director |
BUY
Open market or private purchase
|
Direct |
1,000
+14.29%
|
$2,000
$2.71 P/Share
|
|
Mar 17
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
50,000
+2.74%
|
$100,000
$2.64 P/Share
|
|
Mar 17
2016
|
Panna Sharma Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
500
+0.33%
|
$1,000
$2.58 P/Share
|
|
Mar 16
2016
|
Michael J. Welsh Director |
BUY
Open market or private purchase
|
Direct |
40
+0.79%
|
$80
$2.42 P/Share
|
|
Mar 16
2016
|
Panna Sharma Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.65%
|
$2,000
$2.6 P/Share
|
|
Mar 16
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
10,579
+0.61%
|
$21,158
$2.62 P/Share
|
|
Mar 15
2016
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
89,421
+4.97%
|
$178,842
$2.52 P/Share
|
|
Mar 15
2016
|
Panna Sharma Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+0.66%
|
$2,000
$2.56 P/Share
|
|
Nov 12
2015
|
Edward J Sitar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+22.22%
|
-
|
|
Nov 12
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
100,000
+5.81%
|
-
|
|
Oct 14
2015
|
John Pappajohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.16%
|
-
|
|
Oct 14
2015
|
Raju S.K. Chaganti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.42%
|
-
|
|
Aug 27
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
2,500
+0.16%
|
$25,000
$10.25 P/Share
|
|
Aug 26
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
2,500
+0.16%
|
$20,000
$8.97 P/Share
|
|
Jul 08
2015
|
Rita Shaknovich Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+50.0%
|
-
|
|
Jun 25
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
5,296
-2.99%
|
$63,552
$12.0 P/Share
|
|
Jun 12
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
7,000
-3.8%
|
$84,000
$12.01 P/Share
|
|
Jun 11
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
15,900
-10.36%
|
$190,800
$12.05 P/Share
|
|
Jun 10
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
22,817
-12.95%
|
$273,804
$12.03 P/Share
|
|
Jun 09
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
7,737
-4.21%
|
$92,844
$12.01 P/Share
|
|
Jun 08
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
24,583
-13.36%
|
$294,996
$12.03 P/Share
|
|
May 29
2015
|
Steven Hepburn VP of Biopharma Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+50.0%
|
-
|
|
May 14
2015
|
Howard Mc Leod Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 14
2015
|
Geoffrey E. Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
May 14
2015
|
Geoffrey E. Harris Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$50,000
$10.79 P/Share
|
|
May 14
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.33%
|
$50,000
$10.74 P/Share
|
|
Mar 17
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
15,000
+0.98%
|
$105,000
$7.15 P/Share
|
|
Mar 16
2015
|
Edward J Sitar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+7.41%
|
$6,000
$6.99 P/Share
|
|
Mar 16
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
35,000
+2.28%
|
$245,000
$7.45 P/Share
|
|
Dec 16
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
5,589
+0.38%
|
$33,534
$6.2 P/Share
|
|
Dec 15
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
3,634
+0.25%
|
$21,804
$6.14 P/Share
|
|
Dec 12
2014
|
Edward J Sitar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+4.17%
|
$3,000
$6.26 P/Share
|
|
Dec 11
2014
|
Panna Sharma Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+40.0%
|
-
|
|
Dec 11
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
27,087
+1.83%
|
$162,522
$6.03 P/Share
|
|
Dec 10
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
5,773
+0.4%
|
$28,865
$5.96 P/Share
|
|
Dec 09
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
15,986
+1.11%
|
$79,930
$5.7 P/Share
|
|
Dec 08
2014
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
23,700
+1.66%
|
$118,500
$5.11 P/Share
|
|
Jun 10
2014
|
John Pappajohn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,288
+3.1%
|
$177,152
$4.0 P/Share
|
|
May 22
2014
|
Keith L Brownlie Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 22
2014
|
Edmund Cannon Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+31.46%
|
-
|
|
May 22
2014
|
Franklyn G Prendergast Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 22
2014
|
John Pappajohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+1.83%
|
-
|
|
May 22
2014
|
Panna Sharma Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|